The Fallacy of the Consultation and Informed Consent Process in Radiation Oncology Through the Lens of Prostate Cancer
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
SEARCH · Search NASA
Results for “prostate cancer”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Quality of Life After Prostate Cancer Treatment
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial
The phase 1 portion of this multicenter, phase 1/2 study of hypofractionated (HypoFx) prostate bed radiation therapy (RT) as salvage or adjuvant therapy aimed to identify the shortest dose-fractionation schedule with acceptable toxicity. The phase 2 portion aimed to assess the health-related quality of life (QoL) of using this HypoFx regimen.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Elective Nodal Radiotherapy for Prostate Cancer: For None, Some, or all?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study
To investigate fully balanced steady-state free precession (bSSFP) with optimized acquisition protocols for magnetic resonance imaging (MRI)-based postimplant quality assessment of low-dose-rate (LDR) prostate brachytherapy without an endorectal coil (ERC).
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Posterior Margins in Prostate Cancer Radiation Therapy
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Brachytherapy Boost in Prostate Cancer: What Does Observational Data Add to the Debate?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Management Strategy of High-Risk Localized Prostate Cancer: Is there a Transatlantic Consensus?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and Coming
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Photons, Protons, SBRT, Brachytherapy—What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Underascertainment of Clinically Meaningful Symptoms During Prostate Cancer Radiation Therapy—Does This Vary by Patient Characteristics?
It is well known that physicians underascertain chemotherapy-related toxicity compared with patient self-report. However, symptom underascertainment in radiation therapy and characterization of patient groups at increased risk for underascertainment have not been examined.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
First-In-Human Validation of CT-Based Proton Range Prediction Using Prompt Gamma Imaging in Prostate Cancer Treatments
Uncertainty in computed tomography (CT)-based range prediction substantially impairs the accuracy of proton therapy. Direct determination of the stopping-power ratio (SPR) from dual-energy CT (DECT) has been proposed (DirectSPR), and initial validation studies in phantoms and biological tissues have proven a high accuracy. However, a thorough validation of range prediction in patients has not yet been achieved by any means. Here, we present the first systematic validation of CT-based proton range prediction in patients using prompt gamma imaging (PGI).
62 RADIOLOGY AND NUCLEAR MEDICINE↗
miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA
Not Available
Ray, Jessica↗